Oragenics, Inc.
OGEN · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $28 | $11 | $73,372 |
| - Cash | $11,404 | $1,974 | $3,421 | $865 |
| + Debt | $0 | $3,000 | $2,554 | $329 |
| Enterprise Value | – | $1,054 | -$855 | $72,835 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $64 | -$1,700 | -$2,018 | -$3,338 |
| % Margin | – | – | – | – |
| Net Income | -$3,067 | -$2,272 | -$2,217 | -$3,349 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.96 | -3.1 | -3.6 | -0.51 |
| % Growth | 36.8% | 13.9% | -605.9% | – |
| Operating Cash Flow | -$2,985 | -$1,314 | -$2,112 | -$2,018 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,985 | -$1,314 | -$2,112 | -$2,018 |